{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T10:31:45Z","timestamp":1720348305047},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2016,9,14]]},"DOI":"10.18632\/aging.101046","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T15:54:45Z","timestamp":1473954885000},"page":"1838-1843","source":"Crossref","is-referenced-by-count":3,"title":["Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer\u2019s disease patients"],"prefix":"10.18632","volume":"8","author":[{"given":"Tohru","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Saga Woman Junior College, Saga 840-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ukai","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Sapporo Medical University, School of Medicine, S-1, W-16, Chuo-ku, Sapporo, 0608543, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics.","volume":"1","author":"De Strooper","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"2","unstructured":"Bapineuzumab Phase 3: Target Engagement. But No Benefit. Alzheimer Research Forum. September 12, 2012. Available at http:\/\/www.Alzforum.org\/ new\/detail.asp?id=3268"},{"key":"3","unstructured":"The Solanezumab Benefit. Oh. So, Small, But Probably Real. Alzheimer Research Forum. October 9, 2012. Available at http:\/\/www.Alzforum.org\/new\/detail.asp?id=3288"},{"key":"4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: a crucial factor in Alzheimer\u2019s disease.","volume":"2","author":"Mahmoudi","year":"2015","journal-title":"Med Princ Pract"},{"key":"5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly.","volume":"6","author":"Lopresti","year":"2008","journal-title":"Arch Neurol"},{"key":"6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ygeno.2003.08.018","article-title":"Functional rescue of vitamin C synthesis deficiency in human cells using adenoviral-based expression of murine l-gulono-gamma-lactone oxidase.","volume":"8","author":"Schellhorn","year":"2004","journal-title":"Genomics"},{"key":"7","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1073\/pnas.072033799","article-title":"A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP.","volume":"9","author":"LaFerla","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1172\/JCI112440","article-title":"Relationship of superoxide production to cytoplasmic free calcium in human monocytes.","volume":"7","author":"Lichtman","year":"1986","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","article-title":"Genetics of Alzheimer\u2019s disease: a centennial review.","volume":"2","author":"Ertekin-Taner","year":"2007","journal-title":"Neurol Clin"},{"key":"10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.biocel.2012.07.019","article-title":"Presenilins: role in calcium homeostasis.","volume":"4","author":"Herms","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0304-3940(96)13087-1","article-title":"Physiological levels of beta-amyloid peptide promote PC12 cell proliferation.","volume":"21","author":"Wolozin","year":"1996","journal-title":"Neurosci Lett"},{"key":"12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1006\/dbio.1994.1055","article-title":"The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis.","volume":"16","author":"Allinquant","year":"1994","journal-title":"Dev Biol"},{"key":"13","first-page":"4487","article-title":"APP is required during an early phase of memory formation.","volume":"1","author":"Rose","year":"2000","journal-title":"Eur J Neurosci"},{"key":"14","first-page":"5531","article-title":"The production of amyloid beta peptide is a critical requirement for the viability of central neurons.","volume":"2","author":"Pearson","year":"2003","journal-title":"J Neurosci"},{"key":"15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0173(03)00174-7","article-title":"Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.","volume":"4","author":"Martins","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1113\/jphysiol.2006.111203","article-title":"Physiological roles for amyloid beta peptides.","volume":"57","author":"Peers","year":"2006","journal-title":"J Physiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function.","volume":"3","author":"Malinow","year":"2003","journal-title":"Neuron"},{"key":"18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1101\/lm.1310209","article-title":"Amyloid beta mediates memory formation.","volume":"1","author":"Alberini","year":"2009","journal-title":"Learn Mem"},{"key":"19","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.","volume":"2","author":"Arancio","year":"2008","journal-title":"J Neurosci"},{"key":"20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ana.22313","article-title":"Endogenous amyloid-\u03b2 is necessary for hippocampal synaptic plasticity and memory.","volume":"6","author":"Arancio","year":"2011","journal-title":"Ann Neurol"},{"key":"21","first-page":"441","article-title":"A physiological role for amyloid-beta protein:enhancement of learning and memory.","volume":"1","author":"Xu","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u2019s disease amyloid beta peptide.","volume":"176","author":"Barnham","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"23","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1021\/bi802361k","article-title":"Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.","volume":"4","author":"Fischer","year":"2009","journal-title":"Biochemistry"},{"key":"24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainresrev.2004.05.001","article-title":"Amyloid-beta: phylogenesis of a chameleon.","volume":"4","author":"Atwood","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"25","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u2019s disease amyloid beta peptide.","volume":"176","author":"Barnham","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"26","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1021\/bi802361k","article-title":"Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.","volume":"4","author":"Fischer","year":"2009","journal-title":"Biochemistry"},{"key":"27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainresrev.2004.05.001","article-title":"Amyloid-beta: phylogenesis of a chameleon.","volume":"4","author":"Atwood","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"28","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1523\/JNEUROSCI.0974-04.2004","article-title":"Neurogenic effect of beta-amyloid peptide in the development of neural stem cells.","volume":"2","author":"Shelanski","year":"2004","journal-title":"J Neurosci"},{"key":"29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1471-4159.2007.04499.x","article-title":"Effects of the monomeric, oligomeric, and fibrillar Abeta42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zone.","volume":"10","author":"Suh","year":"2007","journal-title":"J Neurochem"},{"key":"30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/cdd.2008.94","article-title":"Abeta40 promotes neuronal cell fate in neural progenitor cells.","volume":"1","author":"Dong","year":"2009","journal-title":"Cell Death Differ"},{"key":"31","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective.","volume":"2","author":"Copani","year":"2009","journal-title":"J Neurosci"},{"key":"32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.","volume":"25","author":"Kirschner","year":"1990","journal-title":"Science"},{"key":"33","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.neurobiolaging.2013.05.011","article-title":"A\u03b2 increases neural stem cell activity in senescence-accelerated SAMP8 mice.","volume":"3","author":"Mira","year":"2013","journal-title":"Neurobiol Aging"},{"key":"34","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.neurobiolaging.2008.02.004","article-title":"Abeta(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor.","volume":"3","author":"Coulson","year":"2009","journal-title":"Neurobiol Aging"},{"key":"35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/517426a","article-title":"Ageing research: blood to blood.","volume":"51","author":"Scudellari","year":"2015","journal-title":"Nature"},{"key":"36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function.","volume":"47","author":"Park","year":"2011","journal-title":"Nature"},{"key":"37","first-page":"512","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.","volume":"48","author":"Zlokovic","year":"2012","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Blood-Brain Barrier Breakdown in the Aging Human Hippocampus. Neuron. 2015; 85:296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032.","DOI":"10.1016\/j.neuron.2014.12.032"},{"key":"39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-2012-120022","article-title":"Urinary homocysteic acid levels correlate with mini-mental state examination scores in Alzheimer\u2019s disease patients.","volume":"3","author":"Tabira","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM. B6 deficient feeding or homocysteic acid induces the earlier Alzheimer\u2019s pathological change in normal C57BL male mice. Nature Precedings. 2009. http:\/\/hdl.handle.net\/10101\/npre.2009.2764.1.","DOI":"10.1038\/npre.2009.2764.1"},{"key":"41","doi-asserted-by":"publisher","first-page":"e8593","DOI":"10.1371\/journal.pone.0008593","article-title":"Treatment of Alzheimer\u2019s disease with anti-homocysteic acid antibody in 3xTg-AD male mice.","volume":"5","author":"LaFerla","year":"2010","journal-title":"PLoS One"},{"key":"42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jnr.20514","article-title":"Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer\u2019s disease.","volume":"8","author":"Yamada","year":"2005","journal-title":"J Neurosci Res"},{"key":"43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-510X(95)00309-P","article-title":"NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow.","volume":"13","author":"Lehmann","year":"1996","journal-title":"J Neurol Sci"},{"key":"44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01243418","article-title":"Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor.","volume":"7","author":"Cu\u00e9nod","year":"1988","journal-title":"J Neural Transm"},{"key":"45","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/rcm.4447","article-title":"Conversion of methionine into homocysteic acid in heavily oxidized proteomics samples.","volume":"2","author":"Sharp","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-015-0057-0","article-title":"Is L-methionine a trigger factor for Alzheimer\u2019s-like neurodegeneration?: changes in A\u03b2 oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice.","volume":"1","author":"Inestrosa","year":"2015","journal-title":"Mol Neurodegener"},{"key":"47","unstructured":"http:\/\/www.alz.org\/research\/science\/alzheimers_treatment_horizon.asp#hope."},{"key":"48","doi-asserted-by":"publisher","first-page":"707","DOI":"10.18632\/aging.100690","article-title":"Reversal of cognitive decline: a novel therapeutic program.","volume":"6","author":"Bredesen","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18632\/aging.100267","article-title":"Treating transgenic Alzheimer mice with a \u03b2-secretase inhibitor, what have we learned?","volume":"3","author":"Ghosh","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.18632\/aging.100672","article-title":"Ribonucleoprotein therapy in Alzheimer\u2019s disease?","volume":"6","author":"Gorospe","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"51","unstructured":"https:\/\/www.alz.org\/aaic\/_downloads\/thurs-1130am-exercise.pdf."}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:21:58Z","timestamp":1599063718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,30]]}},"alternative-id":["101046","27632569"],"URL":"https:\/\/doi.org\/10.18632\/aging.101046","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}